Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
soreness on her left arm; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included hydrochlorothiazide. On 24-JAN-2025, the patient received the 1st dose of Shingrix. On 25-JAN-2025, 1 days after receiving Shingrix, the patient experienced pain in arm (Verbatim: soreness on her left arm). The outcome of the pain in arm was not resolved. It was unknown if the reporter considered the pain in arm to be related to Shingrix. It was unknown if the company considered the pain in arm to be related to Shingrix. Additional Information: GSK receipt date: 28-APR-2025 The patient reported that she experiencing soreness on her left arm after receiving the first dose of Shingrix vaccine. The batch number and expiry date was unknown.
HYDROCHLOROTHIAZIDE